chr1-26779234-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_006015.6(ARID1A):āc.5336A>Gā(p.Glu1779Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0014 in 1,614,112 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. E1779E) has been classified as Likely benign.
Frequency
Consequence
NM_006015.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARID1A | NM_006015.6 | c.5336A>G | p.Glu1779Gly | missense_variant | 20/20 | ENST00000324856.13 | NP_006006.3 | |
ARID1A | NM_139135.4 | c.4685A>G | p.Glu1562Gly | missense_variant | 20/20 | NP_624361.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARID1A | ENST00000324856.13 | c.5336A>G | p.Glu1779Gly | missense_variant | 20/20 | 1 | NM_006015.6 | ENSP00000320485.7 |
Frequencies
GnomAD3 genomes AF: 0.00102 AC: 156AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00116 AC: 291AN: 251322Hom.: 0 AF XY: 0.00121 AC XY: 165AN XY: 135828
GnomAD4 exome AF: 0.00144 AC: 2102AN: 1461780Hom.: 3 Cov.: 31 AF XY: 0.00141 AC XY: 1028AN XY: 727172
GnomAD4 genome AF: 0.00102 AC: 156AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.00126 AC XY: 94AN XY: 74470
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | ARID1A: BP4, BS1 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 19, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 11, 2020 | This variant is associated with the following publications: (PMID: 29273094, 24382590, 28767289) - |
not specified Benign:1Other:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 29, 2017 | - - |
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
ARID1A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 26, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Intellectual disability, autosomal dominant 14 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at